Scott L. Burrows - Chief Financial Officer at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
SYRE on Nasdaq
All Insider Reports
All Insider Reports

Scott L. Burrows - trading volume in the past year for Spyre Therapeutics, Inc.

Holdings reported by Scott L. Burrows for Spyre Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 116K $3.28M $28.17 Sep 3, 2024 Direct
Stock Option (Right to Buy) 70K Feb 1, 2024 Direct Common Stock

Transactions reported by Scott L. Burrows for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.